CALYX is a new clinical trial in cALD by Minoryx Therapuetics
This trial could be suitable if you are an adult male with AMN or cALD
Key Inclusion Criteria
- X-ALD males aged ≥ 18
- With Gadoliniumenhancing brain lesions
- Loes Score ≥0.5 and ≤12Genetic
For more information about the study, please visit: clinical trial information
To view PDF version of the poster: CALYX flyer
